Hey everyone,
I've went through lots of reading material regarding medical devices and in-vitro diagnostic devices under the European MDR/IVDR but I'm not quite sure about the following:
A medical device software that creates information based on data obtained by in vitro diagnostic medical devices only, is considered an IVD software. So far, simple enough.
However, does that also apply to a software that reuses already processed data (secondary data) by an IVD device and creates new information? Let's say a laboratory analyses a sample of blood and hands out a test result. If I now put these test results into an app that aids in further diagnosis for example, would that make the app an IVD software even though no blood specimen was directly involved?
Also, from practical standpoint: Is there a tangible regulatory difference between being classified as a medical device software or as a IVD software (let's assume either Class IIb for a medical device software or Class C if it's a IVD software)?
Would love to hear your thoughts,
Cheers!
I've went through lots of reading material regarding medical devices and in-vitro diagnostic devices under the European MDR/IVDR but I'm not quite sure about the following:
A medical device software that creates information based on data obtained by in vitro diagnostic medical devices only, is considered an IVD software. So far, simple enough.
However, does that also apply to a software that reuses already processed data (secondary data) by an IVD device and creates new information? Let's say a laboratory analyses a sample of blood and hands out a test result. If I now put these test results into an app that aids in further diagnosis for example, would that make the app an IVD software even though no blood specimen was directly involved?
Also, from practical standpoint: Is there a tangible regulatory difference between being classified as a medical device software or as a IVD software (let's assume either Class IIb for a medical device software or Class C if it's a IVD software)?
Would love to hear your thoughts,
Cheers!